Continuum of

Progress

A main actor in pharmaceutical synthesis and specialty ingredients

A leader in pharmaceutical synthesis

Offering a wide range of technologies, Seqens provide its clients custom manufacturing services as well as a large portfolio of APIs & intermediates. We offer our customers with an access to our network of 3 R&D centers, 4 pilot units and 12 cGMP manufacturing sites and 6 cGMP multi-purposes sites to ensure a smooth in-house scale-up from early clinical phases to the commercial stage.

Discover

Cross-functional knowledge in specialty ingredients

Seqens offers a wide continuum of technologies covering small-scale to large-scale chemical synthesis and distillation including distinctive reactions such as Fiedel-Craft, Grignard and low-metal capabilities. This industrial network is supported by focused R&D capabilities. Seqens offers high purity oxygenated solvents leveraging its back-integrationl and a large range of Minerals Specialties produced.

Discover

A large expertise
in cosmetics

Seqens has built a wide, comprehensive and cutting edge offer for the cosmetic market sourced in pharmaceutics and fine chemistry know-hows.

Discover

A continuum of technologies

Seqens operates 24 industrial plants and 3 R&D centers in Europe, North America and Asia.

More than 300 scientists, engineers and experts develop tailor-made solutions for its customers and ensure that products are successfully transferred into production.

Newsroom

#Live

Products & Technologies

Bicarbonate sodium used in dialysis

Interview of Elsa Prous, Market Manager and Global Key Account Manager & Sophie Mouzon, Development Quality & Customer Assistance Manager of…
General

New kid on the block

THE PAST FEW YEARS have seen the rise of a major player in pharmaceutical CDMO services in Seqens. The name is pronounced like…
General

Seqens North America Named Best Pharmaceutical Synthesis Company 2019

It is always surprising and humbling to be notified that you have won awards you haven’t applied for: no submission, no abstract, no…

Seqens global presence

Use interactive map
0

Employees

0

Scientists, experts and engineers

0

Manufacturing sites

0

Customers in more than 80 countries